Hedge funds gain edge by doubling biotech investments.
Ransom
John
J
D001709:Biotechnology / Q000191:economics* / Q000639:trends; D002202:Capital Financing / Q000191:economics* / Q000639:trends*; D007449:Investments / Q000191:economics* / Q000639:trends*; D010067:Ownership / Q000191:economics* / Q000639:trends*; D014481:United States